Stevens-Johnson syndrome cost-effectiveness of therapy: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
To date, the treatment of Stevens-Johnson Syndrome is mainly supportive | |||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
Revision as of 20:25, 12 September 2018
Stevens-Johnson syndrome Microchapters |
Differentiating Stevens-Johnson Syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Stevens-Johnson syndrome cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Stevens-Johnson syndrome cost-effectiveness of therapy |
FDA on Stevens-Johnson syndrome cost-effectiveness of therapy |
CDC on Stevens-Johnson syndrome cost-effectiveness of therapy |
Stevens-Johnson syndrome cost-effectiveness of therapy in the news |
Blogs on Stevens-Johnson syndrome cost-effectiveness of therapy |
Risk calculators and risk factors for Stevens-Johnson syndrome cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
To date, the treatment of Stevens-Johnson Syndrome is mainly supportive